H.PIO Co., Ltd. (KOSDAQ:357230)
South Korea · Delayed Price · Currency is KRW 2,405.00
-20.00 (-0.82%)
At close: Feb 13, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 99.27 billion as of February 13, 2026. Its market cap has decreased by -8.36% in one year.
Market Cap
99.27B
Enterprise Value
112.74B
Revenue
257.56B
Ranking
n/a
PE Ratio
15.67
Stock Price
2,405.00
Market Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 99.27B, a decrease of -70.28%. That is a compound annual growth rate of -22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 99.27B | -0.62% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | 333.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 132.90B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 113.27B |
| Pharos iBio | 110.17B |
| Ahn-Gook Pharmaceutical | 100.24B |
| Sam-A Pharm. | 98.51B |
| Daehan Nupharm | 93.62B |
| Hwail Pharmaceutical | 91.03B |
| Sinsin Pharmaceutical | 89.96B |